Integrated therapy of cancer of the maxillary antrum

At the University of Louisville Radiation Center, from 1960 through 1969, 24 patients with cancer of the maxillary antrum were seen, and all were treated with megavoltage radiotherapy. All have been followed continuously from the initiation of radiotherapy until the present time or until their death. Survivors in the series have now lived from 33 to 93 months and, with one exception, have remained free of recurrence. The best survival rates are in a group treated with high‐dose preoperative radiotherapy followed, after an appropriate waiting period, by radical surgery. Sixteen patients were treated in this fashion. Their management and the results of their treatment are discussed.